Abstract
Dasatinib-Blinatumomab Combination for the Front-Line Treatment of Adult Ph+ ALL Patients. Updated Results of the Gimema LAL2116 D-Alba Trial
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have